KISS1R and metabolic dysfunction-associated steatotic liver disease: We have previously shown that hepatic KISS1R signaling suppresses the development of MASLD by increasing the b-oxidation of fat via activation of hepatic AMPK thereby attenuating hepatic lipogenesis [8].